Amnesia induced in mice by centrally administered β-amyloid peptides involves cholinergic dysfunction

Brain Research

Volumn 706, Issue 2, 1996, Pages 181-193

  Maurice, Tangui ^a   Lockhart, Brian P ^a,b   Privat, Alain ^a  

^a INSERM   (France)

^b INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

Alternation behavior; Alzheimer's disease; Amnesia model; Neurotoxicity; Passive avoidance; Water maze; Amyloid peptide

Indexed keywords

AMYLOID BETA PROTEIN; NICOTINE; NICOTINIC AGENT; TACRINE;

ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVOIDANCE BEHAVIOR; CHOLINERGIC SYSTEM; CONTROLLED STUDY; HISTOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MAZE TEST; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

EID: 0030048606     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(95)01032-7     Document Type: Article

References (64)

1. Abe, E., Casamenti, F., Giovannelli, L., Scali, C. and Pepeu, G., Administration of amyloid β-petides into the medial septum of rats decreases acetylcholine release from hippocampus in vivo, Brain Res., 636 (1994) 162-164.
2. Amberla, K., Nordberg, A., Viitanen, M. and Winblad, B., Long-term treatment with tacrine (THA) in Alzheimer's disease: evaluation of neuropsychological data, Acta Neurol. Scand. Suppl., 149 (1993) 55-57.
3. Arispe, N., Rojas, E. and Pollard, B., Alzheimer disease amyloid β protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminium, Proc. Natl. Acad. Sci. USA, 90 (1993) 567-571.
4. Bartus, R.T., Dean, I.L., Beer, B. and Lippa, A., The cholinergic hypothesis of geriatric memory dysfuncytion, Science, 217 (1982) 408-417.
5. Bensimon, G. and Chermat, R., Microtubule disruption and cognitive defects: effect of colchicine on learning behaviour in rats, Pharmacol. Biochem. Behav., 38 (1991) 141-146.
6. Clemens, J.A. and Stephenson, D.T., Implants containing beta-amyloid protein are not neurotoxic to young and old rat brain, Neurobiol. Aging, 13 (1992) 581-586.
7. Coyle, J.T., Price, D.L. and DeLong, M.R., Alzheimer's disease: a disorder of cortical cholinergic innervation, Science, 219 (1983) 1184-1190.
8. Davies, L., Wolska, B., Hilbich, C., Multhaup, G., Martins, R., Simms, G., Beyreuther, K. and Masters, C.L., A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques, Neurology, 38 (1988) 1688-1693.
9. Davies, P. and Maloney, A.J.F., Selective loss of central cholinergic neurons in Alzheimer's disease, Lancet, 2 (1976) 1403.
10. Dornan, W.A., Kang, D.E., McCampbell, A. and Kang, E.E., Bilateral injections of beta A(25-35) + IBO into the hippocampus disrupts acquisition of spatial learning in the rat, Neuroreport, 5 (1993) 165-168.
11. Doyle, E., Bruce, M.T., Breen, K.C., Smith, D.C., Anderton, B. and Reagan, C.M, Intraventricular infusions of antibodies to amyloid beta-protein precursor impair the acquisition of a passive avoidance response in the rat, Neurosci. Lett., 115 (1990) 97-102.
12. Drachman, D.A. and Leavitt, J., Human memory and the cholinergic system: a relationship to aging?, Arch. Neurol., 30 (1974) 113-121.
13. Erme, M., Geula, C., Ransil, B.J. and Mesulam, M.M., The acute neurotoxicity and effects upon cholinergic axons or intracerebrally injected beta-amyloid in the rat brain, Neurobiol. Aging, 13 (1992) 553-559.
14. + channels, Science, 264 (1994) 276-279.
15. Farlow, M., Gracon, S.I., Hershey, L.A., Lewis, K.W., Sandowsky, C.H., Dolan-Ureno, J. et al., A controlled trial of tacrine in Alzheimer's disease, J. Am. Med., Assoc., 268 (1992) 2523-2529.
16. Flood, J.F., Morley, J.E. and Roberts, E., Amnestic effects in mice of four synthetic peptides homologous to amyloid β protein from patients with Alzheimer disease, Proc. Natl. Acad. Sci. USA, 88(1991) 3363-3366.
17. Flood, J.F., Roberts, E., Sherman, M.A., Kaplan, B.E. and Morley, J.E., Topography of a binding site for small amnestic peptides deduced from structure-activity studies: relation to amnestic effect of amyloid β protein, Proc. Natl. Acad. Sci. USA, 91 (1994) 380-384.
18. Frautschy, S.A., Baird, A. and Cole, G.M., Effects of injected Alzheimer β-amyloid cores in rat brain, Proc. Natl. Acad. Sci. USA, 88 (1991) 8362-8366.
19. Galdzicki, Z., Fukuyama, R., Wadhwani, K.C., Rapoport, S.I. and Ehrenstein, G., β-Amyloid increases choline conductance of PC12 cells: possible mechanism of toxicity in Alzheimer's disease, Brain Res., 646 (1994) 332-336.
20. Games, D., Khan, K.M., Soriano, F.G., Keim, P.S., Davis, D.L., Bryant, K. and Lieberburg, I., Lack of Alzheimer pathology after beta-amyloid protein injections in rat brain, Neurobiol. Aging, 13 (1992) 569-576.
21. Haley, T.J. and McCormick, W.J., Pharmacological effects produced by intracerebral injections of drugs in the concious mouse, Br. J. Pharmacol., 12 (1957) 12-15.
22. Halverson, K., Frazier, P.E., Kirschner, D.A. and Lansbury, Jr., P.T., Molecular deteminants of amyloid deposition in Alzheimer's disease: conformational studies of synthetic β-protein fragments, Biochemistry, 29 (1990) 2639-2644.
23. Hiramatsu, M., Koide, T., Ishihara, S., Shiotani, T., Kameyama, T. and Nabeshima, T., Involvement of the cholinergic system in the effect of nefiracetam (DM-9384) on carbon monoxide (CO)-induced acute and delayed amnesia, Eur. J. Pharmacol., 216 (1992) 279-285.
24. Itoh, J., Nabeshima, T. and Kameyama, T., Utility of an elevated plus-maze for the evaluation of memory in mice: effects of nootropic, scopolamine and electroconvulsive shock, Psychopharmacology, 101 (1990) 27-33.
25. Knapp, M.J., Knopman, D.S., Solomon, P.R., Pendelbury, W.W., Davis, C.S. and Gracon, S.I., A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The tacrine study group, J. Am. Med. Assoc., (1994) 271 985-991.
26. Kowall, N.W., Beal, M.F., Busciglio, J., Duffy, L.K. and Yanker, B.A., An in vivo model for the neurodegenerative effects of β-amyloid and protection by substance P, Proc. Natl. Acad. Sci. USA, 88 (1991) 7247-7251.
27. Kowall, N.W., McKee, A.C., Yankner, B.A. and Beal, M.F., In vivo neurotoxicity of β-amyloid β(1-40) and the β(25-35) fragment, Neurobiol. Aging, 13 (1992) 537-542.
28. 25-35 peptide-mediated neurotoxicity in rat hippocampal cultures, J. Neurosci. Res., 39 (1994) 494-505.
29. Loo, D.T., Copani, A., Pike, C.J., Whittemore, E.R., Walencewicz, A.J. and Cotman, C.W., Apoptosis is induced by β-amyloid in cultured central nervous system neurons, Proc. Natl. Acad. Sci. USA, 90 (1993) 7951-7955.
30. Maltby, N., Broe, G.A., Creasey, H., Jorm, A.F., Christensen, H. and Brooks, W.S., Efficacy of tacrine and lecithin in mild to moderate Alzheimer's disease: double blind trial, Br. Med. J., 308 (1994) 879-883.
31. 1-40 across the murine blood brain barrier, Life Sci., 55 (1994) 1643-1650.
32. 2+ homeostasis in Alzheimer's disease, Trends Neurosci., 16 (1993) 409-414.
33. Maurice, T., Bayle, J. and Privat, A., Learning impairment following acute administration of the calcium channel antagonist nimodipine in mice, Behav. Pharmacol., 6 (1995) 167-175.
34. Maurice, T., Hiramatsu, M., Kameyama, T., Hasegawa, T. and Nabeshima, T., Cholecystokinin-related peptides, after systemic or central administration, prevent carbon monoxide-induced amnesia in mice, J. Pharmacol. Exp. Ther., 269 (1994) 665-673.
35. McDonald, M.P., Dahl, E.E., Overmier, J.B., Mantyh, P. and Cleary, J., Effects of an exogenous beta-amyloid peptide on retention for spatial learning, Behav. Neur. Biol., 62 (1994) 60-67.
36. Meier-Ruge, W., Hunziker, O. and Iwangoff, P., Senile dementia: a threshold phenomenon of normal aging? A contribution of the functional reserve hypothesis of the brain, Ann. New York Acad. Sci., 621 (1991) 104-118.
37. Miller, C., Haugh, M., Kahn, J. and Anderton, B., The cytoskeleton and neurofibrillary tangles in A.D., Trends Neurosci., 9 (1986) 76-81.
38. Nitta, A., Itoh, A., Hasegawa, T. and Nabeshima, T., β-Amyloid protein-induced Alzheimer's disease animal model, Neurosci. Lett., 170 (1994) 63-66.
39. Parker Jr., W.D., Parks, J., Filley, C.M. and Kleinschmidt-DeMasters, B.K., Electron transport chain defects in Alzheimer's disease brain, Neurology, 44 (1994) 1090-1096.
40. Perry, E.K., Tomlinson, B.E., Blessed, G., Bergman, K., Gibson, P.H. and Perry, R.H., Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia, Br. Med. J., 2 (1978) 1457-1459.
41. Pike, C.J., Burdick, D., Walencewicz, A.J., Glabe, C.G. and Cotman, C.W., Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state, J. Neurosci., 13 (1993) 1676-1687.
42. Pike, C.J., Walencewicz, A.J., Glabe, C.G. and Cotman, C.W., In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity, Brain Res., 563 (1991) 311-314.
43. Podlisny, M.B., Stephenson, D.T., Frosch, M.P., Lieberburg, I., Clemens, J.A. and Selkoe, D.J., Synthetic amyloid beta-protein fails to produce specific neurotoxicity in monkey cerebral cortex, Neurobiol. Aging, 13 (1992) 561-567.
44. Podlisny, M.B., Stephenson, D.T., Frosch, M.P., Tolan, D.R., Lieberburg, I., Clemens, J.A. and Selkoe, D.J., Microinjection of synthetic amyloid beta-protein in monkey cerebral cortex fails to produce acute neurotoxicity, Am. J. Pathol., 142 (1993) 17-24.
45. Regeur, L., Badsberg Jensen, G., Pakkenberg, H., Evans, S.M. and Pakkenberg, B., No global neocortical nerve cell loss in brains from patients with senile dementia of Alzheimer's type, Neurobiol. Aging, in press.
46. Rush, D.K., Aschimes, S. and Merriman, M.C., Intracerebral beta-amyloid(25-35) produces tissue damage: is it neurotoxic?, Neurobiol. Aging, 13 (1992) 591-594.
47. Sahakian, B.J. and Coull, J.T., Tetrahydroaminoacridine (THA) in Alzheimer's disease: an assessment of attentional and mnemonic function using CANTAB, Acta Neurol. Scand. Suppl., 149 (1993) 29-35.
48. Sandbrink, R., Masters, C.L. and Beyreuther, K., Complete nucleotide and deduced amino acid sequence of rat amyloid protein precursor-like protein 2 (APLP2/APPH): two amino acids length difference to human and murine homologues, Biochim. Biophys. Acta, 1219 (1994) 167-170.
49. Sarter, M., Bodewitz, G. and Stephens, D., Attenuation of the scopolamine-induced impairment of spontaneous alternation behaviour by antagonist but not inverse agonist and agonist β-carbolines, Psychopharmacology, 94 (1988) 491-495.
50. Selkoe, D.J., The molecular pathology of Alzheimer's disease, Neuron, 6 (1991) 487-498.
51. Shivers, B.D., Hilbich, C., Multhaup, G., Salbaum, M., Beyreuther, K. and Seeburg, P.H., Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact, EMBO J., (1988) 7, 1365-1370.
52. Simmons, L.K., May, P.C., Tomaselli, K.J., Rydel, R.E., Fuson, K.S., Brigham, E.F., Wright, S., Lieberberg, I., Becker, G.W., Brems, D.N., et al., Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro, Mol. Pharmacol., 45 (1994) 373-379.
53. Simmons, M.A. and Schneider, C.R., Amyloid β peptides act directly on single neurons, Neurosci. Lett., 150 (1993) 133-136.
54. Stein-Behnrens, B., Adams, K., Yeh, M. and Sapolsky, R., Failure of beta-amyloid protein fragment 25-35 to cause hippocampal damage in the rat, Neurobiol. Aging, 13 (1992) 577-579.
55. Swaab, D.F., Hofman, M.A., Lucassen, P.J., Salehi, A. and Uylings, H.B.M., Neuronal atrophy, not cell death, is the main hallmark of Alzheimer's disease, Neurobiol. Aging, 15 (1994) 369-371.
56. Swerdlow, R., Marcus, D.L., Landman, J., Kooby, D., Frey, W. and Freedman, M.L. Brain glucose metabolism in Alzheimer's disease, Am. J. Med. Sci., 308 (1994) 141-144.
57. Waite, J., Cole, G.M., Frautschy, S.A., Connor, D.J. and Thal, L.J., Solvent effects on beta protein toxicity in vivo, Neurobiol. Aging, 13 (1992) 595-599.
58. 2+ channel blockers attenuate β-amyloid peptide toxicity to cortical neurons in culture, J. Neurochem., 62 (1994) 372-375.
59. Whitehouse, P.J., Price, D.L., Struble, R.G., Clark, A.W. and Coyle, J.T., Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain, Science, 215 (1982) 1237-1239.
60. Whitson, J.S., Selkoe, D.G. and Cotman, C.W., Amyloid β-protein enhances the survival of hippocampal neurons in vitro, Science, 243 (1989) 1488-1490.
61. Winkler, J., Conoer, D.J., Frautschy, S.A., Behl, C., Waite, J.J., Cole, G.M. and Thal, L.J., Lack of long-term effects after β-amyloid protein injections in rat brain, Neurobiol. Aging, 15 (1994) 601-607.
62. Yamada, K., Satoh, M., Tokoi, J., Tsuboi, M. and Nagasaka, T., Strain differences of mice in learning of swimming behaviour and effect of hemicholinium and vasopressin. Observation by a simple water maze apparatus, Yakugaku Zasshi, 112 (1992) 824-831.
63. Yamaguchi, F., Richards, S.J., Beyreuther, K., Salbaum, M., Carlson, G.A and Dunnett, S.B., Transgenic mice for the amyloid precursor protein 695 isoform have impared spatial memory, Neuroreport, 2 (1991) 781-784.
64. Yankner, B.A., Duffy, L.K. and Kirschner, D.A., Neurotrophic and neurotoxic effects of amyloid β-protein: reversal by tachykinin neuropeptides, Science, 250 (1990) 279-282.